Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
21 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-completes-acquisition-of-chimerix-302433612.html
21 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/21/3046953/25619/en/Chimerix-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results.html
21 Mar 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/chimerix-engaged-7-other-biopharmas-choosing-jazzs-935m-deal-heres-why-jazz-won
07 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/07/3039230/25619/en/Chimerix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
06 Mar 2025
// PRESS RELEASE
https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-acquire-chimerix-further-diversifying
18 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/18/3027655/25619/en/Chimerix-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Dordaviprone-as-Treatment-for-Recurrent-H3-K27M-Mutant-Diffuse-Glioma.html
ABOUT THIS PAGE